---
title: 'High-Risk MCL: Recognition and Treatment'
date: '2025-01-09'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39786418/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20250110170836&v=2.18.0.post9+e462414
source: Blood
description: Significant progress in determining the molecular origins and resistance
  mechanisms of mantle cell lymphoma (MCL) has improved our understanding of the disease's
  clinical diversity. These factors greatly impact prognosis in MCL patients. Given
  the dynamic alterations in MCL clones and disease evolution, it is crucial to recognize
  high-risk prognostic factors at diagnosis and relapse. Clinical factors include
  a high MCL International Prognostic Index score with a high Ki-67 proliferation
  ...
disable_comments: true
---
Significant progress in determining the molecular origins and resistance mechanisms of mantle cell lymphoma (MCL) has improved our understanding of the disease's clinical diversity. These factors greatly impact prognosis in MCL patients. Given the dynamic alterations in MCL clones and disease evolution, it is crucial to recognize high-risk prognostic factors at diagnosis and relapse. Clinical factors include a high MCL International Prognostic Index score with a high Ki-67 proliferation ...